VTGN (STOCKS)
Vistagen Therapeutics, Inc. Common Stock
$0.590100
+0.029700 (+5.30%)
Prev close: $0.560400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Shawn K. Singh
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $22.88M
- Employees
- 57
- P/E (TTM)
- -0.36
- P/B (TTM)
- 0.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $790.00K |
| Benefits Costs and Expenses | $67.84M |
| Costs And Expenses | $67.84M |
| Operating Expenses | $70.69M |
| Research and Development | $52.02M |
| Other Operating Expenses | $18.57M |
| Operating Income/Loss | -$69.90M |
| Income/Loss From Continuing Operations After Tax | -$67.05M |
| Income/Loss From Continuing Operations Before Tax | -$67.05M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$67.05M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$67.05M |
| Net Income/Loss Available To Common Stockholders, Basic | -$67.05M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.90 |
| Diluted Earnings Per Share | -$1.90 |
| Basic Average Shares | 36,882,840 |
| Diluted Average Shares | 110,141,875 |
| Assets | $65.06M |
| Current Assets | $63.25M |
| Cash | $61.80M |
| Other Current Assets | $1.45M |
| Noncurrent Assets | $1.81M |
| Fixed Assets | $480.00K |
| Other Non-current Assets | $1.33M |
| Liabilities | $14.14M |
| Current Liabilities | $13.53M |
| Accounts Payable | $1.28M |
| Other Current Liabilities | $12.25M |
| Noncurrent Liabilities | $607.00K |
| Equity | $50.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $50.92M |
| Liabilities And Equity | $65.06M |
| Net Cash Flow From Operating Activities | -$60.30M |
| Net Cash Flow From Operating Activities, Continuing | -$60.30M |
| Net Cash Flow From Investing Activities | -$251.00K |
| Net Cash Flow From Investing Activities, Continuing | -$251.00K |
| Net Cash Flow From Financing Activities | $33.21M |
| Net Cash Flow From Financing Activities, Continuing | $33.21M |
| Net Cash Flow | -$27.34M |
| Net Cash Flow, Continuing | -$27.34M |
| Comprehensive Income/Loss | -$67.05M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$67.04M |
| Other Comprehensive Income/Loss | -$32.54M |